BRKR Bruker Corporation

At Pittcon 2006, Bruker Daltonics today announces its new R-series of convenient refrigerated magnets for its apex(R) line of hybrid Fourier Transform mass spectrometers (Q-q-FTMS). Through a joint development between Bruker Daltonics and the Bruker BioSpin group, the R-series magnets incorporate innovative cryostats equipped with cryocooler refrigeration units that replace the conventional liquid nitrogen reservoir. This results in FTMS magnets that do not require liquid nitrogen and require liquid helium only once a year. R-series magnets are available at 7 Tesla (T), 9.4T and 12T field strengths. The new R-series greatly reduces the annual cost of cryogens for FTMS magnets. Another advantage for mass spectrometrists is the convenience of only having to schedule magnet maintenance once a year, whereas traditional FTMS magnets require frequent liquid Nitrogen fills, and periodic liquid Helium fills. The absence of the conventional liquid nitrogen dewar in the R-Series also means that the magnets are smaller, particularly at high field. Additional benefits include a liquid helium reservoir that provides a suitable buffer in the event of a power outage, allowing R-series magnets to stay at field without power for an entire week. Dr. Jeffrey Agar, Assistant Professor of Chemistry at Brandeis University, explains: "Our laboratory studies protein modifications that occur during neurodegeneration, and tries to understand their role in disease progression. We are also studying the role of protein modifications in memory processes, which can involve subtle conformational changes. We use the high-resolution Bruker Daltonics apex-Qe (Q-q-FTMS), equipped with the new refrigerated, low-maintenance 9.4 Tesla magnet. We are particularly pleased with the performance of this new refrigerated magnet from Bruker as it is eco-friendly and improves our research efficiency significantly." Pittcon 2006, the 57th Pittsburgh Conference and Exposition on Analytical Chemistry and Applied Spectroscopy, will be held March 13-16 in Orlando, Florida in the Orange County Convention Center. Bruker Daltonics will exhibit at booth #3155. ABOUT BRUKER BIOSCIENCES (NASDAQ: BRKR) Bruker BioSciences Corporation, headquartered in Billerica, Massachusetts, is the publicly traded parent company of Bruker Daltonics Inc. and Bruker AXS Inc. Bruker Daltonics is a leading developer and provider of innovative life science tools based on mass spectrometry. Bruker AXS is a leading developer and provider of life science, materials research and industrial X-ray analysis tools. For more information about Bruker BioSciences Corporation, please visit www.bruker-biosciences.com CAUTIONARY STATEMENT Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Any forward-looking statements contained herein are based on current expectations, but are subject to a number of risks and uncertainties. The factors that could cause actual future results to differ materially from current expectations include, but are not limited to, risks and uncertainties relating to the companies' reorganization strategies, integration risks, failure of conditions, technological approaches, product development, market acceptance, cost and pricing of the companies' products, changes in governmental regulations, capital spending and government funding policies, FDA and other regulatory approvals to the extent applicable, competition, the intellectual property of others, patent protection and litigation. These and other factors are identified and described in more detail in our filings with the SEC, including, without limitation, our respective annual reports on Form 10-K, our most recent quarterly reports on Form 10-Q, and our current reports on Form 8-K. We disclaim any intent or obligation to update these forward-looking statements.